Kanagawa, Japan

Motoo Tomita

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Japan Science and Technology Agency. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoo Tomita. Retrieved from https://idiyas.com/inventor/motoo-tomita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Motoo Tomita: Innovator in Diabetes Treatment

Introduction

Motoo Tomita is a prominent inventor based in Kanagawa, Japan. He is known for his significant contributions to the field of diabetes treatment, particularly in developing agents that improve insulin resistance. His work has the potential to impact the lives of many individuals suffering from type 2 diabetes.

Latest Patents

Motoo Tomita holds 1 patent related to insulin resistance improving agents. This invention provides a therapeutic agent for type 2 diabetes, which includes a C-terminal globular domain of adiponectin, adiponectin itself, or a gene for the domain or adiponectin. The invention also outlines a method for improving insulin resistance and treating type 2 diabetes through the administration of these agents.

Career Highlights

Tomita is affiliated with the Japan Science and Technology Agency, where he continues to advance research in the field of diabetes. His innovative approach to addressing insulin resistance has garnered attention and recognition within the scientific community.

Collaborations

Some of his notable coworkers include Takashi Kadowaki and Toshimasa Yamauchi, who have collaborated with him on various research projects aimed at improving diabetes treatment.

Conclusion

Motoo Tomita's work in developing insulin resistance improving agents represents a significant advancement in diabetes treatment. His contributions are vital in the ongoing fight against type 2 diabetes, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…